Testosterone Enanthate Cost in Pennsylvania (2026)

What Does Testosterone Enanthate Actually Cost in Pennsylvania?

The average cash-pay price for a 1 mL vial of testosterone enanthate 200 mg/mL at Pennsylvania retail pharmacies sits around $70 per month in 2026. That figure represents the uninsured, no-coupon price across chains like CVS, Rite Aid, and Walgreens locations throughout the state. The manufacturer list price from branded generics hovers near $120 per month, but almost nobody pays list.

Pricing varies by pharmacy and region within the state. Philadelphia-area pharmacies tend to price 5% to 12% higher than rural central Pennsylvania locations due to overhead differences. Costco and independent pharmacies often undercut major chains by $15 to $25 per fill. The FDA-approved prescribing information for testosterone enanthate confirms this is a Schedule III controlled substance, which means every fill requires a valid prescription and DEA-compliant dispensing [1]. Pennsylvania follows the federal scheduling under the Controlled Substances Act without adding further state-level restrictions beyond standard monitoring requirements [2].

Patients filling at Walmart or Costco pharmacies in PA can often find prices between $40 and $55 for a single vial using discount programs. A 10 mL multi-dose vial (the most cost-effective option) brings the per-month cost down to roughly $25 to $35 when purchased out of pocket.

Pennsylvania Medicaid Coverage for Testosterone Enanthate

Pennsylvania Medicaid covers testosterone enanthate for male hypogonadism with prior authorization. The PA requirement means your prescriber must document a clinical diagnosis. Specifically, the prescriber must show two morning serum total testosterone levels below 300 ng/dL, consistent with the Endocrine Society Clinical Practice Guideline threshold for diagnosing testosterone deficiency [3].

Pennsylvania's Medicaid managed care organizations (MCOs), including Highmark Wholecare, UPMC for You, and AmeriHealth Caritas, each maintain their own formulary placement. Most list testosterone enanthate as a preferred injectable, meaning the copay is $0 to $3 for qualifying beneficiaries. The approval turnaround on prior authorization requests is typically 48 to 72 hours. If denied, the prescriber can submit a peer-to-peer review.

Testosterone enanthate is one of the most commonly prescribed formulations for hypogonadism treatment in the U.S. The landmark Testosterone Trials (TTrials) enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL and demonstrated significant improvements in sexual function, physical activity, and mood over 12 months of testosterone gel treatment [4]. While the TTrials used transdermal gel, the physiologic rationale applies identically to enanthate injections, and subsequent analyses confirmed similar benefit profiles across delivery methods. Pennsylvania Medicaid recognizes injectable testosterone as first-line therapy partly because of its lower cost compared to gels and patches, which can run $300 to $500 per month at retail [5].

The American Urological Association (AUA) guideline on testosterone deficiency recommends testosterone therapy for men with consistently low testosterone and associated symptoms, reinforcing the clinical basis that state Medicaid programs rely on when setting coverage criteria [6].

Insurance Coverage Beyond Medicaid

Most commercial health insurance plans operating in Pennsylvania place testosterone enanthate on their formularies. Plans from major PA carriers, including Highmark Blue Cross Blue Shield, UPMC Health Plan, Independence Blue Cross, and Geisinger Health Plan, typically classify it as a Tier 2 preferred generic injectable.

Copays on commercial plans range from $10 to $45 per month depending on the specific plan design. High-deductible health plans (HDHPs) require patients to pay the full negotiated rate until meeting their deductible, but that negotiated rate ($35 to $60 at most PA pharmacies) is often less than the cash price. Plans that require prior authorization follow similar documentation standards to Medicaid: two confirmed low testosterone levels plus symptoms such as fatigue, decreased libido, or reduced muscle mass.

The Endocrine Society's 2018 guideline specifies that testosterone therapy should be initiated only after a confirmed diagnosis with repeat morning testing, since single measurements can be misleading due to diurnal and day-to-day variation [3]. This repeat-testing requirement is the primary reason insurers mandate prior authorization rather than covering the drug on first prescription.

For patients on Medicare Part D in Pennsylvania, testosterone enanthate is covered under the pharmacy benefit. The 2026 Part D redesign caps annual out-of-pocket spending at $2,000, which means even patients paying full price during the deductible phase face a hard ceiling. According to a CMS analysis of Part D spending, testosterone products account for a growing share of endocrine drug utilization among men aged 65 and older [7].

Compounded Testosterone Enanthate in Pennsylvania

Compounded testosterone enanthate is legal in Pennsylvania through licensed 503A compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and must compound pursuant to a valid, patient-specific prescription. The typical compounded price runs about $80 per month, though some compounders charge $50 to $65 for higher-volume vials.

Pennsylvania does not impose additional state-level restrictions on compounded testosterone beyond the federal requirements set by the FDA under Section 503A of the FD&C Act. Compounders must use bulk drug substances from FDA-registered suppliers, and the final product cannot be essentially a copy of a commercially available drug unless there is a documented clinical difference (such as a specific concentration or oil base not available commercially) [8].

One advantage of compounded testosterone in PA is the ability to customize concentration, oil carrier, and vial size. Patients who experience injection-site reactions with the standard cottonseed oil base can request grape seed or sesame oil alternatives. Compounding also allows for higher-concentration preparations (e.g., 250 mg/mL or 300 mg/mL), which reduce injection volume for patients on higher prescribed doses.

Patients should verify that their compounding pharmacy holds a current Pennsylvania Board of Pharmacy compounding license. A 2020 FDA safety communication detailed ongoing quality concerns with certain compounding operations nationwide [9]. Checking the pharmacy's inspection history and accreditation (e.g., PCAB accreditation) adds a layer of safety assurance.

Telehealth Prescribing in Pennsylvania

Pennsylvania permits telehealth prescribing of testosterone enanthate. Prescribers may establish the required patient-provider relationship via synchronous video visit, and both initial evaluation and ongoing monitoring can occur through telehealth platforms operating under PA law.

The Pennsylvania Medical Practice Act was updated to include permanent telehealth provisions, and the state does not require an in-person visit before initiating testosterone therapy, as long as the prescriber completes an adequate evaluation. The evaluation should include symptom assessment, review of prior lab work or ordering of new labs (total testosterone, free testosterone, LH, FSH, CBC, PSA for men over 40), and a discussion of risks and benefits.

Telehealth platforms operating in PA must use prescribers licensed in the Commonwealth. Because testosterone enanthate is a Schedule III controlled substance, the prescriber must also hold a valid DEA registration. The DEA's telemedicine prescribing rules require compliance with the Ryan Haight Act, which permits controlled substance prescribing via telemedicine when a valid practitioner-patient relationship has been established through an approved platform [2].

Monitoring requirements during testosterone therapy include periodic labs. The Endocrine Society guideline recommends checking hematocrit at 3 to 6 months, then annually, because testosterone can stimulate erythropoiesis and raise hematocrit above 54%, increasing the risk of thromboembolic events [3]. A 2010 meta-analysis published in BMC Medicine involving 51 randomized controlled trials and 3,431 men found that testosterone therapy was associated with a statistically significant increase in hemoglobin and hematocrit [10]. These monitoring labs can be ordered through telehealth visits and drawn at any Quest Diagnostics or Labcorp location in Pennsylvania.

How to Get the Lowest Price in Pennsylvania

Several strategies reduce testosterone enanthate costs for PA residents. Here is a ranked approach.

Use a 10 mL multi-dose vial. A 10 mL vial of 200 mg/mL testosterone enanthate contains roughly 8 to 10 weeks of supply at a standard 100 to 200 mg weekly dose. This vial typically costs $50 to $90 at PA pharmacies, bringing the per-week cost under $10 in many cases.

Compare pharmacy prices. Pricing across PA pharmacies varies significantly. Costco (no membership required for pharmacy) and independent pharmacies consistently offer the lowest cash-pay pricing. Use GoodRx, RxSaver, or similar tools to compare real-time prices across your ZIP code.

Manufacturer and pharmacy discount programs. Several generic manufacturers offer savings cards that reduce copays by $15 to $40 per fill. These cards cannot be used with government insurance (Medicaid, Medicare, Tricare) but work with commercial plans and cash-pay purchases. Pharmacy-specific programs like Walmart's ReliOn or Costco Member Prescription Program also apply.

Ask about prior authorization for commercial insurance. Even if your initial claim is rejected, submitting clinical documentation that meets the AUA guideline criteria for testosterone deficiency frequently results in approval on appeal [6]. The required documentation is straightforward: two morning testosterone levels below 300 ng/dL plus at least one qualifying symptom.

Consider a compounding pharmacy for custom needs. If you need a non-standard concentration or oil base, compounded testosterone through a PA-licensed 503A pharmacy runs $50 to $80 per month. This option also bypasses the manufacturer supply chain, which occasionally experiences FDA-tracked shortages [11].

Cardiovascular Safety and Why It Affects Coverage Decisions

The question of testosterone therapy and cardiovascular risk influences how insurers evaluate coverage. The TRAVERSE trial (N=5,204) published in the New England Journal of Medicine in 2023 was the first adequately powered randomized controlled trial to assess major adverse cardiovascular events (MACE) in men with hypogonadism and established or high risk for cardiovascular disease [12]. The trial found that testosterone replacement did not significantly increase the incidence of MACE compared to placebo (hazard ratio 0.99; 95% CI 0.81 to 1.21).

This finding was significant because earlier observational studies had raised concern. A 2013 JAMA study of veterans with low testosterone found higher mortality rates among testosterone users, though methodological critiques later weakened that conclusion [13]. The TRAVERSE data has since led several PA insurers to relax prior-authorization requirements for testosterone therapy in men without pre-existing cardiovascular conditions.

The FDA updated the testosterone labeling in 2015 to require a cardiovascular risk warning on all testosterone products [14]. Despite this label change, the subsequent TRAVERSE trial evidence has shifted clinical practice toward viewing testosterone replacement as cardiovascularly neutral when used in appropriately selected patients with confirmed hypogonadism.

Dosing, Administration, and Ongoing Costs

Standard testosterone enanthate dosing for hypogonadism ranges from 100 mg to 200 mg administered intramuscularly every 7 days, or 50 mg to 100 mg every 3.5 days for more stable serum levels. The Endocrine Society recommends titrating dose based on mid-cycle trough testosterone levels, targeting 400 to 700 ng/dL [3].

Ongoing costs beyond the medication itself include syringes and needles ($5 to $15 per month for a box of 100 at Amazon or a PA pharmacy), alcohol swabs ($3 to $5 per box), and periodic lab work. Labs typically run $50 to $150 out of pocket per panel (total testosterone, free testosterone, estradiol, CBC, CMP, PSA), though most insurance plans cover routine monitoring labs without a separate copay. Telehealth follow-up visits for dose adjustments range from $50 to $150 per visit depending on the platform.

A 2017 pharmacokinetic study confirmed that testosterone enanthate injected intramuscularly reaches peak serum levels within 24 to 48 hours, with a half-life of approximately 4.5 days, supporting the weekly or twice-weekly injection schedule [15]. Patients splitting the weekly dose into two injections may achieve more stable levels and reduce the peak-to-trough fluctuation that causes some men to report mood swings or energy dips at the end of a dosing interval.

Annual all-in costs for a Pennsylvania resident on testosterone enanthate therapy (medication, supplies, labs, and provider visits) typically fall between $1,200 and $2,800 for cash-pay patients, and between $400 and $1,000 for insured patients, depending on copay structure and lab coverage.